| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lb Pharmaceuticals Inc (LBRX) has 16 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. LBRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.69M | $85.88M | - | |
| 10% | 547.6K | $17.51M | - | |
| 10% | 411.7K | $13.16M | - | |
| Dir | 411.7K | $13.16M | - | |
| Other | 195.0K | $6.23M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Deep Track Biotechnology Master Fund, Ltd. | 10% Owner | Buy | 2,666,666 | $15.00 | $39,999,990.00 | +388.6% | +20.4% | - | |
| Sep 12, 2025 | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Buy | 1,000,000 | $15.00 | $15,000,000.00 | +242.9% | +20.4% | - | |
| Sep 12, 2025 | Vida Ventures GP Iii, L.l.c. | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +60.7% | +20.4% | - | |
| Sep 12, 2025 | Nussbaum Ran | Director | Buy | 1,000,000 | $15.00 | $15,000,000.00 | +242.9% | +20.4% | - |